Catalyst Wire Dossier Catalyst Wire Dossier

Triple combination therapy (name undisclosed)

· Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Triple combination therapy (name undisclosed), covering 2014-09-10 to 2014-09-10. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

See pricing